INO
Inovio Pharmaceuticals Inc
1.20$
-3.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.0% | -38.8% | -12.3% | -95.7% | -57.5% | +1,349.3% | +368.4% | -36.6% | +38.6% | -56.4% | +334.8% | -32.6% | +59.4% | -58.0% | +227.0% | -22.4% | +288.0% | -12.8% | +19.4% | -27.8% | -86.5% | +80.2% | -76.1% | +478.2% | -91.9% | -73.8% | -70.0% | |
| – | +0.0% | +21.5% | +32.1% | +186.0% | +11.4% | +97.5% | -98.3% | +9.1% | +8,504.9% | -23.4% | +35.7% | +15.2% | +29.3% | -10.8% | +23.0% | +47.1% | +19.5% | +53.5% | +11.1% | -3.4% | -7.6% | +7.1% | -95.0% | +16.2% | -36.3% | -10.7% | -4.5% | |
| – | +0.0% | -49.0% | -30.2% | -92.5% | -57.5% | +1,349.3% | +350.8% | -38.4% | +48.2% | -56.4% | +334.8% | -32.6% | +59.4% | -58.0% | +227.0% | -22.4% | +288.0% | -12.8% | +19.4% | -27.8% | -86.5% | +80.2% | -76.1% | +478.2% | -91.9% | -450.0% | – | |
| – | +0.0% | -13.9% | -93.4% | +436.5% | -12.9% | +205.0% | +74.9% | -25.7% | +13.1% | -40.3% | +63.6% | +40.9% | +51.1% | -10.2% | +18.8% | +59.6% | +69.5% | +53.5% | +11.1% | -3.4% | -7.6% | +7.1% | +164.5% | -24.7% | -53.8% | -12.8% | -28.3% | |
| – | – | +0.0% | +0.0% | -34.8% | +24.8% | +34.2% | -2.4% | +35.1% | +37.1% | -9.7% | +36.6% | -11.4% | -1.0% | -10.1% | +26.6% | +16.2% | +13.9% | +32.3% | +18.4% | +3.6% | -7.2% | +36.9% | +44.3% | +67.8% | -47.2% | +77,652.6% | -99.9% | |
| – | +0.0% | -6.0% | -46.2% | -13.5% | +9.6% | +88.8% | +39.2% | -4.7% | +23.1% | -23.9% | +46.5% | +9.9% | +26.2% | -10.2% | +21.7% | +42.7% | +51.9% | +48.4% | +12.7% | -1.8% | -7.5% | +14.1% | +130.4% | -8.3% | -47.9% | -23.3% | -21.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | -16.3% | -73.3% | +276.1% | -100.0% | – | -100.0% | – | -98.6% | +21,333.0% | -85.7% | -97.7% | +14,284.0% | +1,687.9% | -96.2% | +54.2% | -97.3% | -81.4% | +1,234.5% | +2,196.7% | +9.5% | -77.7% | -35.2% | -2.5% | -85.5% | -100.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +0.0% | -91.1% | -3,602.5% | – | – | -113.4% | – | – | – | -134.9% | – | – | – | -104.2% | – | – | – | +23.6% | -111.9% | – | -99.2% | +398.5% | -100.0% | -5,357,343,593,800.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.